AA
AlphaCentric Advisors Portfolio holdings
AUM
$100M
This Quarter Return
-2.91%
1 Year Return
+18.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$136M
AUM Growth
+$136M
(-18%)
Cap. Flow
-$37.2M
Cap. Flow
% of AUM
-27.37%
Top 10 Holdings %
Top 10 Hldgs %
25.49%
Holding
262
New
34
Increased
55
Reduced
87
Closed
45
Top Buys
| 1 |
Sarepta Therapeutics
SRPT
|
$1.14M |
| 2 |
Invesco QQQ Trust
QQQ
|
$1.02M |
| 3 |
Invesco NASDAQ 100 ETF
QQQM
|
$1.02M |
| 4 |
Amphastar Pharmaceuticals
AMPH
|
$1M |
| 5 |
Enovis
ENOV
|
$904K |
Top Sells
| 1 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$2.31M |
| 2 |
UroGen Pharma
URGN
|
$2.16M |
| 3 |
Corcept Therapeutics
CORT
|
$2.14M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$1.5M |
| 5 |
Axsome Therapeutics
AXSM
|
$1.41M |
Sector Composition
| 1 | Healthcare | 60.25% |
| 2 | Real Estate | 12.98% |
| 3 | Financials | 6.42% |
| 4 | Industrials | 2.59% |
| 5 | Technology | 2.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Everest Group
EG
$14.6B
| $251K | 0.18% |
659
+14
| +2% | +$5.33K |
|
102
Permian Resources
PR
$9.73B
| $245K | 0.18% |
15,168
+7,683
| +103% | +$124K |
|
103
Gilead Sciences
GILD
$140B
| $240K | 0.18% |
3,500
| – | – |
|
104
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.25B
| $236K | 0.17% |
5,599
-6
| -0.1% | -$253 |
|
105
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.24B
| $236K | 0.17% |
5,843
+41
| +0.7% | +$1.66K |
|
106
SPDR Bloomberg High Yield Bond ETF
JNK
$8.07B
| $236K | 0.17% |
2,504
-7
| -0.3% | -$660 |
|
107
iShares US & Intl High Yield Corp Bond ETF
GHYG
$175M
| $235K | 0.17% |
5,370
-45
| -0.8% | -$1.97K |
|
108
iShares Fallen Angels USD Bond ETF
FALN
$1.86B
| $234K | 0.17% |
8,936
-17
| -0.2% | -$445 |
|
109
Immatics
IMTX
$662M
| $232K | 0.17% |
20,000
+2,500
| +14% | +$29.1K |
|
|
SAFE
110
Safehold
SAFE
$1.16B
| $231K | 0.17% |
11,972
| – | – |
|
111
Kinross Gold
KGC
$26.6B
| $223K | 0.16% |
26,828
+15,806
| +143% | +$132K |
|
112
Copart
CPRT
$46.5B
| $215K | 0.16% |
3,966
+21
| +0.5% | +$1.14K |
|
113
Arthur J. Gallagher & Co
AJG
$77.9B
| $203K | 0.15% |
783
+6
| +0.8% | +$1.56K |
|
114
DaVita
DVA
$9.72B
| $201K | 0.15% |
1,451
+623
| +75% | +$86.3K |
|
115
Roper Technologies
ROP
$56.4B
| $198K | 0.15% |
351
+2
| +0.6% | +$1.13K |
|
116
Broadridge
BR
$29.3B
| $195K | 0.14% |
990
+10
| +1% | +$1.97K |
|
117
Tenet Healthcare
THC
$16.5B
| $195K | 0.14% |
1,466
+584
| +66% | +$77.7K |
|
118
Visa
V
$681B
| $193K | 0.14% |
737
+5
| +0.7% | +$1.31K |
|
119
Pultegroup
PHM
$26.3B
| $191K | 0.14% |
1,733
-1,399
| -45% | -$154K |
|
120
Amphenol
APH
$135B
| $191K | 0.14% |
+2,832
| New | +$191K |
|
121
Cintas
CTAS
$82.9B
| $190K | 0.14% |
+271
| New | +$190K |
|
122
TJX Companies
TJX
$155B
| $190K | 0.14% |
+1,722
| New | +$190K |
|
123
McKesson
MCK
$85.9B
| $184K | 0.14% |
315
+110
| +54% | +$64.2K |
|
124
Brown & Brown
BRO
$31.4B
| $183K | 0.13% |
+2,049
| New | +$183K |
|
125
T-Mobile US
TMUS
$284B
| $181K | 0.13% |
+1,029
| New | +$181K |
|